Antidepressants have higher remission rates and are safe and effective in the short and long-term.

Women with advanced breast cancer who had had transplants experienced remission rates of 50 to 60 percent.

Firstly, the complete remission rates were not high in any group.

Given that the overall remission rate for this group of diseases is not better than approximately 50%, participation in clinical trials is encouraged.

Recent trials are testing newer agents, though the current complete remission rate with these approaches are still low, around 12-20% in most series.

Today, hairy cell leukemia has a high remission rate.

But, remission rates for vilazodone were not significantly different versus placebo.

Although the remission rate is higher in previously untreated patients, relapse occurs soon.

The reasons for these high remission rates are no doubt complex.

The overall cumulative remission rate was 67%.